InsiderTrades

ARCH Venture Partners X, L.P.

SEC CIK 1782583 · EDGAR

Buying vs selling by month open-market trades, last 32 months, all 2 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
PRMEPrime Medicine, Inc.10% 3.20M $20.00M — 12024-02-152024-02-15
NMRANeumora Therapeutics, Inc.10% 2.32M — — 12023-12-082023-12-08

Most active insiders at PRME, 12 months

#InsiderTitleBoughtSold
No open-market trades in the last year.

ARCH Venture Partners X, L.P. made no open-market trades at PRME in the last 12 months.

Transactions 2

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
I 2024-02-20 2024-02-15 PRME Prime Medicine, Inc. ARCH Venture Partners X, L.P. 10% P - Purchase $6.25 +3.20M 3.20M New +$20.00M
MI 2023-12-12 2023-12-08 NMRA Neumora Therapeutics, Inc. ARCH Venture Partners X, L.P. 10% J - Other — +1.88M 2.32M +425% —

Purchase Sale Sale after option exercise All abbreviations